As part of Ensembl’s contribution to the fight against the COVID-19 pandemic, we have brought in some important new COVID-19 mutation data related to rapidly spreading strains and changes in virus effectiveness. This priority set of mutations comes from the COVID-19 Genomics UK Consortium (COG-UK) and is soon to be included in the Ensembl COVID-19 browser.
Continue readingTag: SARS-CoV-2
Training in the Time of Pandemic
Were you planning on attending or hosting an Ensembl workshop in 2020, but your plans got cancelled due to the SARS-CoV-2 pandemic? All is not lost, as we’re still providing live virtual training and here’s how it works.
Continue readingUpdate to the Ensembl COVID-19 resource
We are pleased to announce an updated release of the Ensembl SARS-CoV-2 genome browser, including new sequence variants generated from sequence data held in ENA and updated community annotation.
Continue readingCool stuff the Ensembl VEP can do: annotating SARS-CoV-2 variants
We had a number of queries about the Ensembl VEP related to its support for SARS-CoV-2. Here, we talk about how you can use the command line VEP to analyse your variants against the SARS-CoV-2 gene set from Ensembl.
Continue readingEnsembl launches COVID-19 resource
Today, Ensembl has joined the international scientific effort to tackle the COVID-19 pandemic. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread rapidly since emerging in late 2019. Our SARS-CoV-2 genome browser and related resources at covid-19.ensembl.org are intended to support both basic research and ongoing work to develop treatments, diagnostics and vaccines.
Continue readingGENCODE are updating the annotation of human protein-coding genes linked to COVID-19 disease
The SARS-CoV-2 pandemic presents a serious challenge to healthcare, economies and societies across the globe, one that has demanded an unprecedented scientific response. Projects across multiple disciplines are now re-directing their usual analytical efforts to meet this challenge head-on, and GENCODE are no exception. Our project produces human gene annotation, and we’re contributing to this scientific effort by re-examining human genes that may be relevant to viral infection and COVID-19 disease. We hope this work will support further research along these lines. For example, updated gene annotation could benefit studies to find disease-linked variants in patients with severe COVID-19 symptoms, including work by Genomics England and others.
Continue reading